NNVC Stock In The Limelight After This Analyst Sees A 350% Upside Potential Everything To Know About Its Experimental Drug For Ebola

(MENAFN - AsiaNet News) NanoViricides said its proposal for the Phase II trial has already been approved by the relevant committee in the DRC. The company believes NV-387's broad-spectrum approach ...